Journey Medical Statistics

Total Valuation

DERM has a market cap or net worth of $97.35 million. The enterprise value is $95.75 million.

Market Cap	97.35M
Enterprise Value	95.75M

Important Dates

The last earnings date was Tuesday, November 12, 2024, after market close.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

DERM has 20.89 million shares outstanding. The number of shares has increased by 9.92% in one year.

Current Share Class	14.89M
Shares Outstanding	20.89M
Shares Change (YoY)	+9.92%
Shares Change (QoQ)	+2.72%
Owned by Insiders (%)	5.29%
Owned by Institutions (%)	17.72%
Float	10.43M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.59
Forward PS	1.44
PB Ratio	8.82
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.66
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.38, with a Debt / Equity ratio of 1.93.

Current Ratio	1.38
Quick Ratio	0.99
Debt / Equity	1.93
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-9.52

Financial Efficiency

Return on equity (ROE) is -129.58% and return on invested capital (ROIC) is -42.89%.

Return on Equity (ROE)	-129.58%
Return on Assets (ROA)	-17.33%
Return on Capital (ROIC)	-42.89%
Revenue Per Employee	$1.41M
Profits Per Employee	-$447,220
Employee Count	41
Asset Turnover	0.89
Inventory Turnover	2.16

Taxes

In the past 12 months, DERM has paid $126,000 in taxes.

Income Tax	126,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -38.98% in the last 52 weeks. The beta is 0.90, so DERM's price volatility has been lower than the market average.

Beta (5Y)	0.90
52-Week Price Change	-38.98%
50-Day Moving Average	5.50
200-Day Moving Average	4.83
Relative Strength Index (RSI)	34.32
Average Volume (20 Days)	107,832

Short Selling Information

The latest short interest is 76,739, so 0.37% of the outstanding shares have been sold short.

Short Interest	76,739
Short Previous Month	66,232
Short % of Shares Out	0.37%
Short % of Float	0.74%
Short Ratio (days to cover)	0.55

Income Statement

In the last 12 months, DERM had revenue of $57.77 million and -$18.34 million in losses. Loss per share was -$0.93.

Revenue	57.77M
Gross Profit	33.11M
Operating Income	-18.02M
Pretax Income	-3.94M
Net Income	-18.34M
EBITDA	-14.76M
EBIT	-18.02M
Loss Per Share	-$0.93

Full Income Statement

Balance Sheet

The company has $22.46 million in cash and $21.07 million in debt, giving a net cash position of $1.39 million or $0.07 per share.

Cash & Cash Equivalents	22.46M
Total Debt	21.07M
Net Cash	1.39M
Net Cash Per Share	$0.07
Equity (Book Value)	10.93M
Book Value Per Share	0.53
Working Capital	12.83M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-27.87M
Capital Expenditures	n/a
Free Cash Flow	-27.87M
FCF Per Share	-$1.33

Full Cash Flow Statement

Margins

Gross margin is 57.32%, with operating and profit margins of -31.18% and -31.74%.

Gross Margin	57.32%
Operating Margin	-31.18%
Pretax Margin	-31.52%
Profit Margin	-31.74%
EBITDA Margin	-25.54%
EBIT Margin	-31.18%
FCF Margin	n/a

Dividends & Yields

DERM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.92%
Shareholder Yield	-9.92%
Earnings Yield	-18.88%
FCF Yield	-28.69%

Analyst Forecast

The average price target for DERM is $9.50, which is 103.86% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.50
Price Target Difference	103.86%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

DERM has an Altman Z-Score of -0.73 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.73
Piotroski F-Score	1